Skip to content

Clinical trials

Brain Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Country / region: France Clear all

168 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20022
20031
20044
20052
20062
20074
20084
20095
20104
20114
20126
20136
201410
20156
201614
20175
20184
201911
202014
20218
202210
202312
20246
20259
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86
Recruiting24
Unknown status19
Active, not recruiting16
Terminated13
Not yet recruiting7
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris14
European Organisation for Research and Treatment of Cancer - EORTC9
Novartis Pharmaceuticals7
Centre Francois Baclesse6
University Hospital, Brest5
Assistance Publique Hopitaux De Marseille4
Centre Leon Berard4
Gustave Roussy, Cancer Campus, Grand Paris4
Institut Cancerologie de l'Ouest4
University Hospital, Strasbourg, France4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms168
Glioblastoma29
Glioma25
Breast Neoplasms19
Neoplasms16
Neoplasm Metastasis15
Central Nervous System Neoplasms13
Melanoma12
Carcinoma, Non-Small-Cell Lung11
Gliosarcoma9

Trials

Showing 51 to 75 of 168. Each trial links to its page on Pharma Observatory.

68 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.